BACE1 and glioblastoma: Furthermore, BACE1 reduced the phagocytosis of tumor cells in glioblastoma by activating the tumor-promoting macrophages via cleaving interleukin-6 receptor (IL-6R) and activating IL6/sIL-6R/STAT3 signaling [11].